Skip to main contentSkip to navigation
Sirius Investors

Qiagen N.V. (QGEN) Investment Research Dashboard

About Qiagen N.V. (QGEN) stock analysis

Get live QGEN stock price $41.08, comprehensive Qiagen N.V. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time QGEN stock data and investment insights.

41.08
0.70%Today
Market Cap
8.47B
Volume
1.65M
52W High
57.82
52W Low
32.53

Loading chart data...

Qiagen N.V. (QGEN) Overview

Qiagen N.V. (QGEN) is a publicly traded company in the Healthcare sector , specifically within the Medical - Diagnostics & Research industry . As of the latest trading session, QGEN trades at $41.08 with a market capitalization of 8.47B . Over the past 52 weeks, QGEN has traded between $32.53 and $57.82 , with the current price positioned at approximately 34% of this range . The stock currently...

Key Takeaways

  • Operates in the Healthcare sector (Medical - Diagnostics & Research)
  • Market cap: 8.47B
  • Current price: $41.08
  • 52-week range: $32.53 - $57.82
  • P/E ratio: 17.12

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, man...

Company Information

CEO
Thierry Bernard
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
5736

Contact Information

Address
Hulsterweg 82
Country
NL

Investment Analysis & Business Insights

Healthcare
Medical - Diagnostics & Research

Investment Highlights

Strong presence in the Healthcare sector with established market position

Valuation metrics suggest potential value opportunity (P/E: 17.1)

Lower volatility stock (Beta: 0.64) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Qiagen N.V. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Qiagen N.V.
  • Investors should consider how Qiagen N.V. fits within their overall portfolio allocation

Market Cap

8.47B

P/E Ratio (TTM)

17.12

Beta

0.64

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

72/100 ⭐⭐⭐⭐⭐

Overall
-0.1%
NYSE
-0.1%
NASDAQ
-0.1%
Sector1D1W1MP/EScore
Consumer Defensive+1.3%+3.3%+2.2%29.2
88/100⭐⭐⭐⭐⭐
Financial Services-0.1%+0.9%+2.0%19.3
86/100⭐⭐⭐⭐⭐
Communication Services+0.4%-1.6%+2.0%22.2
74/100⭐⭐⭐⭐⭐
Healthcare-0.1%+0.5%+0.8%23.5
72/100⭐⭐⭐⭐⭐
Basic Materials-0.7%+0.1%-1.3%24.9
60/100⭐⭐⭐⭐
Energy-0.4%-2.0%-2.4%19.4
51/100⭐⭐⭐
Utilities-1.5%-0.5%-4.9%25.4
40/100⭐⭐⭐
Real Estate-1.6%-1.1%-3.5%29.4
36/100⭐⭐
Industrials-0.4%-0.5%-10.7%30.5
19/100
Consumer Cyclical-0.3%-2.3%-6.5%43.1
17/100
Technology-1.9%-4.0%-9.4%41.9
7/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.